← Open Payments lookup

JAMES TRAHAN: Open Payments

NPI 1699863019 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$406 in 14 payments from 8 companies in 2025. Trend: 2023 $343 · 2024 $507 · 2025 $406

Food & beverage: $406
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.2$125
Alkermes, Inc.3$88
Teva Pharmaceuticals USA, Inc.2$53
Neurocrine BioSciences, Inc.2$48
ABBVIE INC.2$39
Otsuka America Pharmaceutical, Inc.1$21
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$19
Noven Therapeutics, LLC1$14

Products named: COBENFY, ARISTADA, AUSTEDO XR, INGREZZA, VRAYLAR, ABILIFY ASIMTUFII, CAPLYTA, Xelstrym.

Industry payments across MO — which companies pay providers there.